Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379281010> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4379281010 endingPage "e18803" @default.
- W4379281010 startingPage "e18803" @default.
- W4379281010 abstract "e18803 Background: CUPs are a heterogeneous group of metastatic cancers for which a standardized diagnostic work-up fails to identify the site of origin at the time of diagnosis. CUP accounts for 3%-5% of all cancer diagnoses worldwide, and the natural history of patient with CUP differs from that of patients (pts) with cancer with known primary tumor. Here we report and summarize the clinical features of patients with CUP treated at Mayo Clinic. Methods: Retrospective study of patients treated at Mayo Clinic Rochester MN from 2010 to 2021. Patient demographics, tumor-related variables, treatment-related variables, and clinical data were extracted. Descriptive statistics were used, and all data were analyzed by the SPSS version 22.0 software (SPSS, Chicago, IL, United States). Results: From a total of 214 pts, 207 pts were included, as primary tumor site was identified in 7 patients after initial evaluation. The pts in this study were predominantly white (87%) of female (50.2%) gender with a mean age of 63 (SD: 13) without history of smoking (51%) and either private or public insurance (82.6%). The predominant histology was adenocarcinoma (30%), followed by neuroendocrine neoplasms (27%), and carcinoma NOS (not otherwise specified) (25%). The most prevalent grade in this cohort was grade III with poorly differentiated tumor cells. All pts had diagnostic imaging and the most used imaging modalities included CT (81.2%), and PET-CT (43.5%). In our cohort, the 3 most common sites of metastases included lymph nodes (57.5%), liver (37.8%), lung (34.3%), and bone (23.7%); and in 64% of pts, there was a specific presentation pattern including liver-predominant (24.6%), lymph node-predominant (24.6%), bone-predominant (7.7%), and peritoneal carcinomatosis (7.7%). The majority of pts received systemic therapy (69%) as first line of therapy and the most frequent first line regimens included platinum-doublet (26.5%), gemcitabine-based regimen (20.7%), 5FU-based regimens (18%) and somatostatin analogs (16.7%); whereas salvage radiation and ablation were offered to 11% of pts and surgery to 17%. The median follow-up time was 22 months (IQR: 45) with a median survival time of 23 months and the 3-year cumulative survival rate was 30%. Conclusions: The heterogenous nature of CUPs and lack of specific immunohistochemical signature prevents primary tissue of origin diagnoses in CUP pts. Without the identification of a primary origin site, treatment is restricted to generic chemotherapy with limited benefit as demonstrated in this cohort." @default.
- W4379281010 created "2023-06-05" @default.
- W4379281010 creator A5000258108 @default.
- W4379281010 creator A5002104514 @default.
- W4379281010 creator A5016389391 @default.
- W4379281010 creator A5037629427 @default.
- W4379281010 creator A5046724542 @default.
- W4379281010 creator A5056681233 @default.
- W4379281010 creator A5063451759 @default.
- W4379281010 creator A5069388227 @default.
- W4379281010 creator A5069569795 @default.
- W4379281010 creator A5088559858 @default.
- W4379281010 creator A5090608376 @default.
- W4379281010 creator A5092083218 @default.
- W4379281010 date "2023-06-01" @default.
- W4379281010 modified "2023-09-26" @default.
- W4379281010 title "Clinicopathological features and treatment patterns of patients with cancer of unknown primary site (CUP): Mayo Clinic experience." @default.
- W4379281010 doi "https://doi.org/10.1200/jco.2023.41.16_suppl.e18803" @default.
- W4379281010 hasPublicationYear "2023" @default.
- W4379281010 type Work @default.
- W4379281010 citedByCount "0" @default.
- W4379281010 crossrefType "journal-article" @default.
- W4379281010 hasAuthorship W4379281010A5000258108 @default.
- W4379281010 hasAuthorship W4379281010A5002104514 @default.
- W4379281010 hasAuthorship W4379281010A5016389391 @default.
- W4379281010 hasAuthorship W4379281010A5037629427 @default.
- W4379281010 hasAuthorship W4379281010A5046724542 @default.
- W4379281010 hasAuthorship W4379281010A5056681233 @default.
- W4379281010 hasAuthorship W4379281010A5063451759 @default.
- W4379281010 hasAuthorship W4379281010A5069388227 @default.
- W4379281010 hasAuthorship W4379281010A5069569795 @default.
- W4379281010 hasAuthorship W4379281010A5088559858 @default.
- W4379281010 hasAuthorship W4379281010A5090608376 @default.
- W4379281010 hasAuthorship W4379281010A5092083218 @default.
- W4379281010 hasConcept C121608353 @default.
- W4379281010 hasConcept C126322002 @default.
- W4379281010 hasConcept C167135981 @default.
- W4379281010 hasConcept C2776256026 @default.
- W4379281010 hasConcept C2779013556 @default.
- W4379281010 hasConcept C2780283643 @default.
- W4379281010 hasConcept C2781182431 @default.
- W4379281010 hasConcept C71924100 @default.
- W4379281010 hasConcept C72563966 @default.
- W4379281010 hasConceptScore W4379281010C121608353 @default.
- W4379281010 hasConceptScore W4379281010C126322002 @default.
- W4379281010 hasConceptScore W4379281010C167135981 @default.
- W4379281010 hasConceptScore W4379281010C2776256026 @default.
- W4379281010 hasConceptScore W4379281010C2779013556 @default.
- W4379281010 hasConceptScore W4379281010C2780283643 @default.
- W4379281010 hasConceptScore W4379281010C2781182431 @default.
- W4379281010 hasConceptScore W4379281010C71924100 @default.
- W4379281010 hasConceptScore W4379281010C72563966 @default.
- W4379281010 hasIssue "16_suppl" @default.
- W4379281010 hasLocation W43792810101 @default.
- W4379281010 hasOpenAccess W4379281010 @default.
- W4379281010 hasPrimaryLocation W43792810101 @default.
- W4379281010 hasRelatedWork W1967103478 @default.
- W4379281010 hasRelatedWork W1971557041 @default.
- W4379281010 hasRelatedWork W2032912323 @default.
- W4379281010 hasRelatedWork W2368013728 @default.
- W4379281010 hasRelatedWork W2372561159 @default.
- W4379281010 hasRelatedWork W2375344515 @default.
- W4379281010 hasRelatedWork W2390152934 @default.
- W4379281010 hasRelatedWork W2400217987 @default.
- W4379281010 hasRelatedWork W2603773853 @default.
- W4379281010 hasRelatedWork W3024699566 @default.
- W4379281010 hasVolume "41" @default.
- W4379281010 isParatext "false" @default.
- W4379281010 isRetracted "false" @default.
- W4379281010 workType "article" @default.